AAM
KYNB

Advisors Asset Management’s Kyntra Bio KYNB Stock Holding History

Advisors Asset Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-316
Closed -$293K – 1497
2020
Q4 		$293K Sell
316
-4
-1% -$4.21K ﹤0.01% 1119
2020
Q3 		$329K Sell
320
-6
-2% -$6.46K 0.01% 1043
2020
Q2 		$330K Sell
326
-3
-0.9% -$2.79K 0.01% 1026
2020
Q1 		$286K Sell
329
-18
-5% -$17.9K 0.01% 1015
2019
Q4 		$372K Sell
347
-5
-1% -$5.11K 0.01% 1067
2019
Q3 		$325K Sell
352
-7
-2% -$7.69K 0.01% 1079
2019
Q2 		$406K Buy
359
+117
+48% +$128K 0.01% 1045
2019
Q1 		$329K Buy
+242
New +$328K 0.01% 1211

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Advisors Asset Management's KYNB Position: Q1 2021 in Review

Advisors Asset Management sold out of Kyntra Bio (KYNB) in Q1 2021, closing a stake of 316 shares — an estimated $293K sold.

Advisors Asset Management first reported a position in KYNB in Q1 2019 and held it in 8 quarters. The position peaked at $406K in Q2 2019. 198 funds tracked by Wall St. Rank hold KYNB as of Q1 2021.

  • Advisors Asset Management reported no remaining Kyntra Bio position as of Q1 2021 after selling out during the quarter.
  • Advisors Asset Management sold 316 Kyntra Bio shares in Q1 2021, an estimated $293K.
  • Advisors Asset Management first reported a position in Kyntra Bio in Q1 2019 and held it in 8 quarters.
  • Advisors Asset Management's Kyntra Bio position peaked at $406K in Q2 2019.
  • 198 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2021.

Based on Advisors Asset Management's 13F filing for Q1 2021, filed 7 May 2021.